DavidBrownMD

Ophthalmology • Bellaire, TX

Retinal Disease

Clinical Professor, Ophthalmology, Baylor College of Medicine

Join to view full profile

Dr. Brown is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Brown's full profile

Already have an account?

Office
4460 Bissonnet
Ste 200
Bellaire, TX 77401
Phone+1 713-524-3434

Fax+1 713-524-3220
Is this information wrong?

Education & Training

University of Iowa Hospitals and ClinicsResidency, Ophthalmology, 1990 - 1995
Baylor College of MedicineInternship, Transitional Year, 1988 - 1988
Baylor College of MedicineClass of 1987

Certifications & Licensure

TX State Medical License 1989 - 2025
LA State Medical License 1996 - 2006
IA State Medical License 1989 - 1997
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow (FACS) American College of Surgeons
Fellow (FAAO) American Academy of Ophthalmology
Join now to see all

Clinical Trials

Pilot Study of X-82 in Patients With Wet AMD Start of enrollment: 2012 Oct 01
Completed
Phase 1, Phase 2
Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion Start of enrollment: 2012 Oct 01
Completed
Phase 4
A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema Start of enrollment: 2013 Nov 01
Completed
Phase 1, Phase 2
Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01
Completed
A Safety And Efficacy Study Of Alg-1001 In Human Subjects With Symptomatic Focal Vitreomacular Adhesion Start of enrollment: 2014 Feb 01
Completed
Phase 2
A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA Start of enrollment: 2014 Aug 01
Completed
Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy. Start of enrollment: 2014 Sep 23
Completed
Phase 2
TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) Start of enrollment: 2017 Apr 01
Completed
Phase 2
A Study to Test Different Doses of BI 836880 in Patients With an Eye Disease Called Wet Age-related Macular Degeneration (wAMD) Start of enrollment: 2019 Jun 27
Completed
Phase 1, Phase 2
A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy Start of enrollment: 2019 Jul 26
Terminated
Phase 1
HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia Start of enrollment: 2020 Jun 12
Completed
Phase 1, Phase 2
A Pharmacokinetic stuDy of intRavitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Diabetic Macular Edema Start of enrollment: 2020 Dec 01
Withdrawn
Phase 2
Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene Start of enrollment: 2020 Dec 04
Active, not recruiting
Phase 3
Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene Start of enrollment: 2020 Dec 04
Active, not recruiting
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

526 citations
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
Pravin U. Dugel, Adrian Koh, Yuichiro Ogura, Glenn J. Jaffe, Ursula Schmidt-Erfurth
Ophthalmology. 2020-01-01
584 citations
Intravitreal aflibercept for diabetic macular edema.
Jean-François Korobelnik, Diana V. Do, Ursula Schmidt-Erfurth, David S. Boyer, Frank G. Holz
Ophthalmology. 2014-11-01
1180 citations
Ranibizumab for Diabetic Macular Edema: Results from 2 Phase III Randomized Trials: RISE and RIDE
Quan Dong Nguyen, David M. Brown, Dennis M. Marcus, David S. Boyer, Sunil S. Patel
Ophthalmology. 2012-04-01

Lectures

Vision and Diabetic Retinopathy Severity Score (DRSS) Following Intravitreal Aflibercept Injection (IAI) in Diabetic Macular Edema (DME) Patients with Hemoglobin A1c (...
Houston, TX - 6/16/2014

Press Mentions

Kodiak Sciences Announces Emerging Durability Data from Ongoing Phase 1b Study of KSI-301 in Wet AMD Patients at the Retina Society Annual MeetingSeptember 15th, 2019
Kodiak Sciences to Release Durability Data from Clinical Development Program of KSI-301 for Wet AMD at the Retina Society Annual MeetingSeptember 12th, 2019
Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Join now to see all